Axsome says U.S. FDA asks for no extra data for depression drug, shares surge | Regina Leader Post

Retrieved on: 2021-08-23 12:11:15

Tags for this article:

Drugs

Psychoactive drugs

Antidepressants

Neurochemistry

Selective serotonin reuptake inhibitors

Chloroarenes

Major depressive disorder

Combination drugs

Sertraline

Bupropion/dextromethorphan

Fluoxetine

Serotonin

Click the tags to see associated articles and topics

Axsome says U.S. FDA asks for no extra data for depression drug, shares surge | Regina Leader Post. View article details on hiswai:

Excerpt

Analysts had expected the FDA to decline Axsome's application, with Truist Securities analyst Joon Lee saying the lack of a “complete response letter” from ...

Article found on: leaderpost.com

View Original Article